Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 5
Psoriasis: Targets and Therapy
- View all (62)
- Volume 8, 2018 (5)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 5, 2015
Links and risks associated with psoriasis and metabolic syndrome
Liakou AI, Zouboulis CC
Psoriasis: Targets and Therapy 2015, 5:125-128
Published Date: 2 November 2015
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
Forchhammer S, Ghoreschi K
Psoriasis: Targets and Therapy 2015, 5:117-124
Published Date: 7 September 2015
Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
Yélamos O, Ros S, Puig L
Psoriasis: Targets and Therapy 2015, 5:109-115
Published Date: 17 July 2015
Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
Rogalski C
Psoriasis: Targets and Therapy 2015, 5:97-107
Published Date: 8 June 2015
Psoriasis in pregnancy: challenges and solutions
Vena GA, Cassano N, Bellia G, Colombo D
Psoriasis: Targets and Therapy 2015, 5:83-95
Published Date: 18 May 2015
Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
Kingsley GH, Scott DL
Psoriasis: Targets and Therapy 2015, 5:71-81
Published Date: 12 May 2015
Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
Manalo IF, Gilbert KE, Wu JJ
Psoriasis: Targets and Therapy 2015, 5:65-70
Published Date: 5 May 2015
Epidemiology and treatment of psoriasis: a Brazilian perspective
Duarte GV, Porto-Silva L, Oliveira MdeFP
Psoriasis: Targets and Therapy 2015, 5:55-64
Published Date: 17 April 2015
Psoriasis in childhood: effective strategies to improve treatment adherence
Shah KN, Cortina S, Ernst MM, Kichler JC
Psoriasis: Targets and Therapy 2015, 5:43-54
Published Date: 16 March 2015
Clinical potential of brodalumab in the management of psoriasis: the evidence to date
Sandoval LF, Williams B, Feldman SR
Psoriasis: Targets and Therapy 2015, 5:35-41
Published Date: 11 March 2015
Optimal management of nail disease in patients with psoriasis
Piraccini BM, Starace M
Psoriasis: Targets and Therapy 2015, 5:25-33
Published Date: 9 January 2015
Fumaric acid esters in the management of psoriasis
Balak DMW
Psoriasis: Targets and Therapy 2015, 5:9-23
Published Date: 5 January 2015
Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study
Narayanan S, Guyatt V, Franceschetti A, Hautamaki EL
Psoriasis: Targets and Therapy 2015, 5:1-7
Published Date: 23 December 2014